subscribeSubscribe
RedHill and HealthCare Agree to Extinguish All RedHill`s Debt Obligations

RedHill and HealthCare Agree to Extinguish All RedHill`s Debt Obligations
PR NEWSWIRE
06 Feb 2023
Share Share
Grunenthal and Kyowa Announce Collaboration for Established Medicines Portfolio

Grunenthal and Kyowa Announce Collaboration for Established Medicines Portfolio
BUSINESSWIRE
25 Nov 2022
Share Share
RedHill Biopharma Introduces Three New Analyzes of Movantik Data

RedHill Biopharma Introduces Three New Analyzes of Movantik Data
PRNEWSWIRE
08 Sep 2021
Share Share
RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021

RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021
PRNEWSWIRE
07 Sep 2021
Share Share
AstraZeneca completes divestment of Movantik to RedHill Biopharma

AstraZeneca completes divestment of Movantik to RedHill Biopharma
PHARMABIZ
02 Apr 2020
Share Share
AZ licences Movantik rights to RedHill

AZ licences Movantik rights to RedHill
Selina McKee PHARMA TIMES
01 Apr 2020
Share Share
AstraZeneca offloads most global rights for GI med Movantik

AstraZeneca offloads most global rights for GI med Movantik
K. Blankenship FIERCE PHARMA
26 Feb 2020
Share Share
FDA Confirms Paragraph IV Patent Challenge of Movantik (Naloxegol) 12.5 mg and 25 mg Tablets

FDA Confirms Paragraph IV Patent Challenge of Movantik (Naloxegol) 12.5 mg and 25 mg Tablets
FDA
12 Dec 2018
Share Share
List of Paragraph IV Patent Certifications (PPIV) as of December 3, 2018

List of Paragraph IV Patent Certifications (PPIV) as of December 3, 2018
FDA
12 Dec 2018
Share Share
BMS looks for Opdivo convenience edge with new 4-week dosing

BMS looks for Opdivo convenience edge with new 4-week dosing
Carly Helfand FIERCE PHARMA
06 Mar 2018
Share Share